{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:09:52Z","timestamp":1792782592554,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Major Research Plan of the National Natural Science Foundation of China","award":["92374108"],"award-info":[{"award-number":["92374108"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Math. Biol."],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00285-026-02443-w","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:42:35Z","timestamp":1786030955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Complex bifurcation dynamics of tumor\u2013immune interactions incorporating combination therapies"],"prefix":"10.1007","volume":"93","author":[{"given":"Yue","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5294-0764","authenticated-orcid":false,"given":"Xiufen","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"2443_CR1","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nrc2256","volume":"7","author":"JA Aguirre-Ghiso","year":"2007","unstructured":"Aguirre-Ghiso JA (2007) Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 7:834\u2013846. https:\/\/doi.org\/10.1038\/nrc2256","journal-title":"Nat Rev Cancer"},{"key":"2443_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103864","volume":"180","author":"A Aisa","year":"2022","unstructured":"Aisa A, Weng S, Li X, Zhang D, Yuan Y (2022) Immune checkpoint inhibitors combined with HER-2 targeted therapy in HER-2 positive gastroesophageal cancer. Crit Rev Oncol Hematol 180:103864. https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103864","journal-title":"Crit Rev Oncol Hematol"},{"key":"2443_CR3","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1016\/j.vaccine.2020.02.034","volume":"38","author":"TC Albershardt","year":"2020","unstructured":"Albershardt TC, Parsons AJ, Reeves RS, Flynn PA, Campbell DJ, Meulen JT, Berglund P (2020) Therapeutic efficacy of PD1\/PDL1 blockade in B16 melanoma is greatly enhanced by immunization with dendritic cell-targeting lentiviral vector and protein vaccine. Vaccine 38:3369\u20133377. https:\/\/doi.org\/10.1016\/j.vaccine.2020.02.034","journal-title":"Vaccine"},{"key":"2443_CR4","doi-asserted-by":"publisher","unstructured":"Anderson HG, Takacs GP, Harris DC, Kuang Y, Harrison JK, Stepien TL (2024a) Global stability and parameter analysis reinforce therapeutic targets of PD-L1-PD-1 and MDSCs for glioblastoma. J Math Biol 88:10. https:\/\/doi.org\/10.1007\/s00285-023-02027-y","DOI":"10.1007\/s00285-023-02027-y"},{"key":"2443_CR5","doi-asserted-by":"publisher","unstructured":"Anderson HG, Takacs GP, Harrison JK, Rong LB, Stepien TL (2024b) Optimal control of combination immunotherapy in a glioblastoma-immune dynamics model. J Theor Biol 595:111951. https:\/\/doi.org\/10.1101\/2024.04.29.591725","DOI":"10.1101\/2024.04.29.591725"},{"key":"2443_CR6","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1200\/jco.2016.34.2_suppl.625","volume":"34","author":"M Ball","year":"2016","unstructured":"Ball M, Johnson M, Gorin M, Rodriguez M, Zhang M, Papadopoulos N, Haffner M, Hammers H, Marchionni L, Netto G, Drake C, Allaf M (2016) Clinical, pathologic and genomic profiles of exceptional responders to anti-PD1 therapy in renal cell carcinoma. J Clin Oncol 34:625. https:\/\/doi.org\/10.1200\/jco.2016.34.2_suppl.625","journal-title":"J Clin Oncol"},{"key":"2443_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2024.102422","volume":"90","author":"B Bareham","year":"2024","unstructured":"Bareham B, Dibble M, Parsons M (2024) Defining and modeling dynamic spatial heterogeneity within tumor microenvironments. Curr Opin Cell Biol 90:102422. https:\/\/doi.org\/10.1016\/j.ceb.2024.102422","journal-title":"Curr Opin Cell Biol"},{"key":"2443_CR8","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.jaad.2020.03.131","volume":"83","author":"DM Barrios","year":"2020","unstructured":"Barrios DM, Do MH, Phillips GS, Postow MA, Akaike T, Nghiem P, Lacouture ME (2020) Immune checkpoint inhibitors to treat cutaneous malignancies. J Am Acad Dermatol 83:1239\u20131253. https:\/\/doi.org\/10.1016\/j.jaad.2020.03.131","journal-title":"J Am Acad Dermatol"},{"key":"2443_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jtho.2023.09.075","volume":"18","author":"M Bittoni","year":"2023","unstructured":"Bittoni M, Harper A, Wu A, Florez N, King J, Erwin R, Addario B, Carbone D, Gitlitz B, Nieva J (2023) OA13. 06 The epidemiology of young lung cancer: Interim analysis of risk factors and genetic mutations. J Thorac Oncol 18:75\u201376. https:\/\/doi.org\/10.1016\/j.jtho.2023.09.075","journal-title":"J Thorac Oncol"},{"key":"2443_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.critrevonc.2018.12.002","volume":"135","author":"M Caccese","year":"2019","unstructured":"Caccese M, Indraccolo S, Zagonel V, Lombardi G (2019) PD-1\/PD-L1 immune-checkpoint inhibitors in glioblastoma: a concise review. Crit Rev Oncol Hematol 135:128\u2013134. https:\/\/doi.org\/10.1016\/j.critrevonc.2018.12.002","journal-title":"Crit Rev Oncol Hematol"},{"key":"2443_CR11","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.1126\/scitranslmed.adl3598","volume":"16","author":"Z Chen","year":"2024","unstructured":"Chen Z, Ji W, Feng W, Cui J, Wang Y, Li F, Chen J, Guo Z, Xia L, Zhu X, Niu X, Zhang Y, Li Z, Wong AST, Lu S, Xia W (2024) PTPRT loss enhances anti-PD-1 therapy efficacy by regulation of STING pathway in non-small cell lung cancer. Sci Transl Med 16:3598. https:\/\/doi.org\/10.1126\/scitranslmed.adl3598","journal-title":"Sci Transl Med"},{"key":"2443_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtbi.2023.111630","volume":"575","author":"B Delamonica","year":"2023","unstructured":"Delamonica B, Bal\u00e1zs G, Shub M (2023) Cusp bifurcation in a metastatic regulatory network. J Theor Biol 575:111630. https:\/\/doi.org\/10.1016\/j.jtbi.2023.111630","journal-title":"J Theor Biol"},{"key":"2443_CR13","volume-title":"AUTO-07P: continuation and bifurcation software for ordinary differential equations","author":"EJ Doedel","year":"2007","unstructured":"Doedel EJ, Champneys AR, Dercole F, Fairgrieve TF, Kuznetsov YA, Oldeman B, Paffenroth RC, Sandstede B, Wang XJ, Zhang CH (2007) AUTO-07P: continuation and bifurcation software for ordinary differential equations. Concordia University, Montreal"},{"key":"2443_CR14","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1073\/pnas.1910856117","volume":"117","author":"JA Flores-Toro","year":"2020","unstructured":"Flores-Toro JA, Luo DF, Gopinath A, Sarkisian MR, Campbell JJ, Charo IF, Singh R, Schall TJ, Datta M, Jain RK, Mitchell DA, Harrison JK (2020) CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas. Proc Natl Acad Sci USA 117:1129\u20131138. https:\/\/doi.org\/10.1073\/pnas.1910856117","journal-title":"Proc Natl Acad Sci USA"},{"key":"2443_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","volume":"9","author":"DI Gabrilovich","year":"2009","unstructured":"Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9:162\u2013174. https:\/\/doi.org\/10.1038\/nri2506","journal-title":"Nat Rev Immunol"},{"key":"2443_CR16","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.jaad.2020.03.132","volume":"83","author":"AN Geisler","year":"2020","unstructured":"Geisler AN, Phillips GS, Barrios DM, Wu J, Leung DY, Moy AP, Kern JA, Lacouture ME (2020) Immune checkpoint inhibitor-related dermatologic adverse events. J Am Acad Dermatol 83:1255\u20131268. https:\/\/doi.org\/10.1016\/j.jaad.2020.03.132","journal-title":"J Am Acad Dermatol"},{"key":"2443_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109272","volume":"27","author":"Y Gu","year":"2024","unstructured":"Gu Y, Liu Q, He QX, Wu QS, Li LY, Xu DC, Zheng LY, Xie L, Cheng SL, Shen HZ, Zhou YF, Yang JF, Jin HB, Zhang XF (2024) LC3-dependent extracellular vesicles promote M-MDSC accumulation and immunosuppression in colorectal cancer. iScience 27:109272. https:\/\/doi.org\/10.1016\/j.isci.2024.109272","journal-title":"iScience"},{"key":"2443_CR18","volume-title":"Nonlinear oscillations, dynamical systems, and bifurcations of vector fields","author":"J Guckenheimer","year":"2013","unstructured":"Guckenheimer J, Holmes P (2013) Nonlinear oscillations, dynamical systems, and bifurcations of vector fields. Springer, New York"},{"key":"2443_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.lungcan.2021.12.015","volume":"165","author":"LN He","year":"2022","unstructured":"He LN, Chen T, Fu S, Chen C, Jiang YL, Zhang XY, Du W, Li HF, Wang YX, Ali WAS, Zhou YX, Lin Z, Yang YP, Huang Y, Zhao HY, Fang WF, Zhang L, Hong SD (2022) Reducing number of target lesions for RECIST1. 1 to predict survivals in patients with advanced non-small-cell lung cancer undergoing anti-PD1\/PD-L1 monotherapy. Lung Cancer 165:10\u201317. https:\/\/doi.org\/10.1016\/j.lungcan.2021.12.015","journal-title":"Lung Cancer"},{"key":"2443_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.lfs.2015.01.011","volume":"124","author":"S Horibe","year":"2015","unstructured":"Horibe S, Matsuda A, Tanahashi T, Inoue J, Kawauchi S, Mizuno S, Ueno M, Takahashi K, Maeda Y, Maegouchi T, Murakami Y, Yumoto RO, Nagai J, Takano M (2015) Cisplatin resistance in human lung cancer cells is linked with dysregulation of cell cycle associated proteins. Life Sci 124:31\u201340. https:\/\/doi.org\/10.1016\/j.lfs.2015.01.011","journal-title":"Life Sci"},{"key":"2443_CR21","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1093\/nar\/gkae973","volume":"53","author":"S Jiang","year":"2025","unstructured":"Jiang S, Li H, Zhang L, Mu W, Zhang Y, Chen T, Wu J, Tang H, Zheng S, Liu Y, Wu Y, Luo X, Xie Y, Ren J (2025) Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics. Nucleic Acids Res 53:1670\u20131676. https:\/\/doi.org\/10.1093\/nar\/gkae973","journal-title":"Nucleic Acids Res"},{"key":"2443_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s002850050127","volume":"37","author":"D Kirschner","year":"1998","unstructured":"Kirschner D, Panetta JC (1998) Modeling immunotherapy of the tumor\u2013immune interaction. J Math Biol 37:235\u2013252","journal-title":"J Math Biol"},{"key":"2443_CR23","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1158\/2326-6066.CIR-22-0617","volume":"11","author":"J Kreger","year":"2023","unstructured":"Kreger J, Roussos Torres ET, MacLean AL (2023) Myeloid-derived suppressor-cell dynamics control outcomes in the metastatic niche. Cancer Immunol Res 11:614\u2013628. https:\/\/doi.org\/10.1158\/2326-6066.CIR-22-0617","journal-title":"Cancer Immunol Res"},{"key":"2443_CR24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0092-8240(05)80260-5","volume":"56","author":"VA Kuznetsov","year":"1994","unstructured":"Kuznetsov VA, Makalkin IA, Taylor MA, Perelson AS (1994) Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis. Bull Math Biol 56:295\u2013321. https:\/\/doi.org\/10.1016\/S0092-8240(05)80260-5","journal-title":"Bull Math Biol"},{"key":"2443_CR25","volume-title":"Elements of applied bifurcation theory","author":"YA Kuznetsov","year":"1998","unstructured":"Kuznetsov YA, Kuznetsov IA, Kuznetsov Y (1998) Elements of applied bifurcation theory. Springer, New York"},{"key":"2443_CR26","doi-asserted-by":"publisher","first-page":"0178479","DOI":"10.1371\/journal.pone.0178479","volume":"12","author":"X Lai","year":"2017","unstructured":"Lai X, Friedman A (2017) Combination therapy of cancer with cancer vaccine and immune checkpoint inhibitors: a mathematical model. PLoS ONE 12:0178479. https:\/\/doi.org\/10.1371\/journal.pone.0178479","journal-title":"PLoS ONE"},{"key":"2443_CR27","doi-asserted-by":"publisher","first-page":"7627","DOI":"10.1016\/j.jde.2017.08.023","volume":"263","author":"F Li","year":"2017","unstructured":"Li F, Liu B (2017) Bifurcation for a free boundary problem modeling the growth of tumors with a drug induced nonlinear proliferation rate. J Differ Equ 263:7627\u20137646. https:\/\/doi.org\/10.1016\/j.jde.2017.08.023","journal-title":"J Differ Equ"},{"key":"2443_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106939","volume":"88","author":"L Li","year":"2020","unstructured":"Li L, Yu R, Cai T, Chen Z, Lan M, Zou T, Wang B, Wang Q, Zhao Y, Cai Y (2020) Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment. Int Immunopharmacol 88:106939. https:\/\/doi.org\/10.1016\/j.intimp.2020.106939","journal-title":"Int Immunopharmacol"},{"key":"2443_CR29","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","volume":"6","author":"K Li","year":"2021","unstructured":"Li K, Shi H, Zhang B, Ou X, Ma Q, Chen Y, Shu P, Li D, Wang Y (2021) Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer. Signal Transduct Target Ther 6:362. https:\/\/doi.org\/10.1038\/s41392-021-00670-9","journal-title":"Signal Transduct Target Ther"},{"key":"2443_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109367","volume":"113","author":"X Li","year":"2022","unstructured":"Li X, Ma S, Gao T, Mai Y, Song Z, Yang J (2022) The main battlefield of mRNA vaccine-tumor immune microenvironment. Int Immunopharmacol 113:109367. https:\/\/doi.org\/10.1016\/j.intimp.2022.109367","journal-title":"Int Immunopharmacol"},{"key":"2443_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216906","volume":"592","author":"Z Li","year":"2024","unstructured":"Li Z, Xia Q, He YJ, Li L, Yin PH (2024) MDSCs in bone metastasis: mechanisms and therapeutic potential1. Cancer Lett 592:216906. https:\/\/doi.org\/10.1016\/j.canlet.2024.216906","journal-title":"Cancer Lett"},{"key":"2443_CR32","doi-asserted-by":"publisher","first-page":"4336","DOI":"10.1182\/blood-2006-09-046201","volume":"109","author":"C Liu","year":"2007","unstructured":"Liu C, Yu S, Kappes J, Wang J, Grizzle WE, Zinn KR, Zhang HG (2007) Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. Blood 109:4336\u20134342. https:\/\/doi.org\/10.1182\/blood-2006-09-046201","journal-title":"Blood"},{"key":"2443_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001895","volume":"9","author":"C Liu","year":"2021","unstructured":"Liu C, Liu R, Wang B, Lian J, Yao Y, Sun H, Zhang C, Fang L, Guan X, Shi J, Han S, Zhan F, Luo S, Yao Y, Zheng T, Zhang Y (2021) Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer. J Immunother Cancer 9:001895. https:\/\/doi.org\/10.1136\/jitc-2020-001895","journal-title":"J Immunother Cancer"},{"key":"2443_CR34","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.physa.2018.11.039","volume":"517","author":"JP Mendon\u00e7a","year":"2019","unstructured":"Mendon\u00e7a JP, Gleria I, Lyra ML (2019) Delay-induced bifurcations and chaos in a two-dimensional model for the immune response. Physica A 517:484\u2013490. https:\/\/doi.org\/10.1016\/j.physa.2018.11.039","journal-title":"Physica A"},{"key":"2443_CR35","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jtho.2017.11.135","volume":"13","author":"ED Miller","year":"2018","unstructured":"Miller ED, Fisher JL, Haglund KE, Grecula JC, Xu-Welliver M, Bertino EM, He K, Shields PG, Carbone DP, Williams TM, Otterson GA, Bazan JG (2018) The addition of chemotherapy to radiation therapy improves survival in elderly patients with stage III non-small cell lung cancer. J Thorac Oncol 13:426\u2013435. https:\/\/doi.org\/10.1016\/j.jtho.2017.11.135","journal-title":"J Thorac Oncol"},{"key":"2443_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122387","volume":"338","author":"S Najafi","year":"2024","unstructured":"Najafi S, Mortezaee K (2024) Modifying CAR-T cells with anti-checkpoints in cancer immunotherapy: a focus on anti PD-1\/PD-L1 antibodies. Life Sci 338:122387. https:\/\/doi.org\/10.1016\/j.lfs.2023.122387","journal-title":"Life Sci"},{"key":"2443_CR37","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0025-5564(99)00058-9","volume":"163","author":"F Nani","year":"2000","unstructured":"Nani F, Freedman HI (2000) A mathematical model of cancer treatment by immunotherapy. Math Biosci 163:159\u2013199. https:\/\/doi.org\/10.1016\/S0025-5564(99)00058-9","journal-title":"Math Biosci"},{"key":"2443_CR38","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.alit.2022.01.001","volume":"71","author":"N Okiyama","year":"2022","unstructured":"Okiyama N, Tanaka R (2022) Immune-related adverse events in various organs caused by immune checkpoint inhibitors. Allergol Int 71:169\u2013178. https:\/\/doi.org\/10.1016\/j.alit.2022.01.001","journal-title":"Allergol Int"},{"key":"2443_CR39","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.neuron.2020.09.018","volume":"108","author":"C Pasqualini","year":"2020","unstructured":"Pasqualini C, Kozaki T, Bruschi M, Nguyen THH, Minard-Colin V, Castel D, Grill J, Ginhoux F (2020) Modeling the interaction between the microenvironment and tumor cells in brain tumors. Neuron 108:1025\u20131044. https:\/\/doi.org\/10.1016\/j.neuron.2020.09.018","journal-title":"Neuron"},{"key":"2443_CR40","volume-title":"Differential equation and dynamical systems","author":"L Perko","year":"2013","unstructured":"Perko L (2013) Differential equation and dynamical systems. Springer, New York"},{"key":"2443_CR41","doi-asserted-by":"publisher","first-page":"15572","DOI":"10.1073\/pnas.242358099","volume":"99","author":"RM Ribeiro","year":"2002","unstructured":"Ribeiro RM, Mohri H, Ho DD, Perelson AS (2002) In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: Why are CD4+ but not CD8+ T cells depleted? Proc Natl Acad Sci USA 99:15572\u201315577. https:\/\/doi.org\/10.1073\/pnas.242358099","journal-title":"Proc Natl Acad Sci USA"},{"key":"2443_CR42","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.amc.2014.01.111","volume":"232","author":"FA Rihan","year":"2014","unstructured":"Rihan FA, Rahman DA, Lakshmanan S, Alkhajeh AS (2014) A time delay model of tumour\u2013immune system interactions: global dynamics, parameter estimation, sensitivity analysis. Appl Math Comput 232:606\u2013623. https:\/\/doi.org\/10.1016\/j.amc.2014.01.111","journal-title":"Appl Math Comput"},{"key":"2443_CR43","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jconrel.2015.10.055","volume":"220","author":"M Roblek","year":"2015","unstructured":"Roblek M, Calin M, Schlesinger M, Stan D, Zeisig R, Simionescu M, Bendas G, Borsig L (2015) Targeted delivery of CCR2 antagonist to activated pulmonary endothelium prevents metastasis. J Control Rel 220:341\u2013347. https:\/\/doi.org\/10.1016\/j.jconrel.2015.10.055","journal-title":"J Control Rel"},{"key":"2443_CR44","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13058-018-1037-4","volume":"20","author":"RR Rosato","year":"2018","unstructured":"Rosato RR, D\u00e1vila-Gonz\u00e1lez D, Choi DS, Qian W, Chen W, Kozielski AJ, Kozielski AJ, Wong H, Dave B, Chang JC (2018) Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models. Breast Cancer Res 20:108. https:\/\/doi.org\/10.1186\/s13058-018-1037-4","journal-title":"Breast Cancer Res"},{"key":"2443_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2022.110461","volume":"100","author":"RSA Sattar","year":"2022","unstructured":"Sattar RSA, Ali A, Sharma AK, Kumar A, Santoshi S, Saluja SS (2022) Molecular pathways in periampullary cancer: an overview. Cell Signal 100:110461. https:\/\/doi.org\/10.1016\/j.cellsig.2022.110461","journal-title":"Cell Signal"},{"key":"2443_CR46","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1053\/j.seminoncol.2020.05.003","volume":"47","author":"C Shah","year":"2020","unstructured":"Shah C, Bauer-Nilsen K, McNulty RH, Vicini F (2020) Novel radiation therapy approaches for breast cancer treatment. Semin Oncol 47:209\u2013216. https:\/\/doi.org\/10.1053\/j.seminoncol.2020.05.003","journal-title":"Semin Oncol"},{"key":"2443_CR47","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1053\/j.seminoncol.2023.12.001","volume":"50","author":"J Shain","year":"2023","unstructured":"Shain J, Michel A, May MS, Qunaj L, El-Sadr W, Chung WK, Appelbaum PS, Jacobson JS, Justman J, Neugut AI (2023) Cancer genetic mutation prevalence in sub-Saharan Africa: a review of existing data. Semin Oncol 50:123\u2013130. https:\/\/doi.org\/10.1053\/j.seminoncol.2023.12.001","journal-title":"Semin Oncol"},{"key":"2443_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jtbi.2018.01.006","volume":"442","author":"SP Shariatpanahi","year":"2018","unstructured":"Shariatpanahi SP, Madjidzadeh K, Hassan M, Abedi-Valugerdi M (2018) Mathematical modeling of tumor-induced immunosuppression by myeloid-derived suppressor cells: implications for therapeutic targeting strategies. J Theor Biol 442:1\u201310. https:\/\/doi.org\/10.1016\/j.jtbi.2018.01.006","journal-title":"J Theor Biol"},{"key":"2443_CR49","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3934\/dcdsb.2020157","volume":"26","author":"S Shi","year":"2021","unstructured":"Shi S, Huang J, Kuang Y (2021) Global dynamics in a tumor-immune model with an immune checkpoint inhibitor. Discrete Contin Dyn Syst Ser B 26:1149\u20131170. https:\/\/doi.org\/10.3934\/dcdsb.2020157","journal-title":"Discrete Contin Dyn Syst Ser B"},{"key":"2443_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cnsns.2022.106996","volume":"118","author":"S Shi","year":"2023","unstructured":"Shi S, Huang J, Kuang Y, Ruan S (2023) Stability and Hopf bifurcation of a tumor-immune system interaction model with an immune checkpoint inhibitor. Commun Nonlinear Sci Numer Simul 118:106996. https:\/\/doi.org\/10.1016\/j.cnsns.2022.106996","journal-title":"Commun Nonlinear Sci Numer Simul"},{"key":"2443_CR51","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.drudis.2019.11.003","volume":"25","author":"S Singh","year":"2020","unstructured":"Singh S, Hassan D, Aldawsari HM, Molugulu N, Shukla R, Kesharwani P (2020) Immune checkpoint inhibitors: a promising anticancer therapy. Drug Discov Today 25:223\u2013229. https:\/\/doi.org\/10.1016\/j.drudis.2019.11.003","journal-title":"Drug Discov Today"},{"key":"2443_CR52","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fphys.2020.00151","volume":"11","author":"KM Storey","year":"2020","unstructured":"Storey KM, Lawler SE, Jackson TL (2020) Modeling oncolytic viral therapy, immune checkpoint inhibition, and the complex dynamics of innate and adaptive immunity in glioblastoma treatment. Front Physiol 11:151. https:\/\/doi.org\/10.3389\/fphys.2020.00151","journal-title":"Front Physiol"},{"key":"2443_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188460","volume":"1875","author":"M \u015awierczy\u0144ski","year":"2021","unstructured":"\u015awierczy\u0144ski M, Szymaszkiewicz A, Fichna J, Zieli\u0144ska M (2021) New insights into molecular pathways in colorectal cancer: adiponectin, interleukin-6 and opioid signaling. Biochim Biophys Acta Rev Cancer 1875:188460. https:\/\/doi.org\/10.1016\/j.bbcan.2020.188460","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2443_CR54","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1016\/j.physd.2008.03.044","volume":"237","author":"G Tanaka","year":"2008","unstructured":"Tanaka G, Tsumoto K, Tsuji S, Aihara K (2008) Bifurcation analysis on a hybrid systems model of intermittent hormonal therapy for prostate cancer. Phys D 237:2616\u20132627. https:\/\/doi.org\/10.1016\/j.physd.2008.03.044","journal-title":"Phys D"},{"key":"2443_CR55","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1189\/jlb.1107774","volume":"84","author":"MW Teng","year":"2008","unstructured":"Teng MW, Swann JB, Koebel CM, Schreiber RD, Smyth MJ (2008) Immune-mediated dormancy: an equilibrium with cancer. J Leukoc Biol 84:988\u2013993. https:\/\/doi.org\/10.1189\/jlb.1107774","journal-title":"J Leukoc Biol"},{"key":"2443_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.mbs.2024.109145","volume":"369","author":"G Torres-Espino","year":"2024","unstructured":"Torres-Espino G, Vidal C (2024) Dynamics aspects and bifurcations of a tumor-immune system interaction under stationary immunotherapy. Math Biosci 369:109145. https:\/\/doi.org\/10.1016\/j.mbs.2024.109145","journal-title":"Math Biosci"},{"key":"2443_CR57","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/s42003-020-01441-y","volume":"3","author":"MM Tu","year":"2020","unstructured":"Tu MM, Abdel-Hafiz HA, Jones RT, Jean A, Hoff KJ, Duex JE, Chauca-Diaz A, Costello JC, Dancik GM, Tamburini BAJ, Czerniak B, Kaye J, Theodorescu D (2020) Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy. Commun Biol 3:720. https:\/\/doi.org\/10.1038\/s42003-020-01441-y","journal-title":"Commun Biol"},{"key":"2443_CR58","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mattod.2022.11.008","volume":"62","author":"ZY Wan","year":"2023","unstructured":"Wan ZY, Huang HZ, West RE III, Zhang M, Zhang B, Cai XR, Zhang ZQ, Luo ZY, Chen Y, Zhang Y, Xie W, Yang D, Nolin TD, Wang JM, Li S, Sun JJ (2023) Overcoming pancreatic cancer immune resistance by codelivery of CCR2 antagonist using a STING-activating gemcitabine-based nanocarrier. Mater Today 62:33\u201350. https:\/\/doi.org\/10.1016\/j.mattod.2022.11.008","journal-title":"Mater Today"},{"key":"2443_CR59","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.nonrwa.2014.03.001","volume":"19","author":"Z Wang","year":"2014","unstructured":"Wang Z (2014) Bifurcation for a free boundary problem modeling tumor growth with inhibitors. Nonlinear Anal Real World Appl 19:45\u201353. https:\/\/doi.org\/10.1016\/j.nonrwa.2014.03.001","journal-title":"Nonlinear Anal Real World Appl"},{"key":"2443_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104702","volume":"25","author":"H Wang","year":"2022","unstructured":"Wang H, Zhao C, Santa-Maria CA, Emens LA, Popel AS (2022) Dynamics of tumor-associated macrophages in a quantitative systems pharmacology model of immunotherapy in triple-negative breast cancer. IScience 25:104702. https:\/\/doi.org\/10.1016\/j.isci.2022.104702","journal-title":"IScience"},{"key":"2443_CR61","doi-asserted-by":"publisher","first-page":"22541","DOI":"10.1038\/s41598-023-49467-6","volume":"13","author":"Y Wang","year":"2023","unstructured":"Wang Y, Bergman DR, Trujillo E, Pearson AT, Sweis RF, Jackson TL (2023) Mathematical model predicts tumor control patterns induced by fast and slow cytotoxic T lymphocyte killing mechanisms. Sci Rep 13:22541. https:\/\/doi.org\/10.1038\/s41598-023-49467-6","journal-title":"Sci Rep"},{"key":"2443_CR62","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0169-5002(18)30113-2","volume":"115","author":"M Wright","year":"2018","unstructured":"Wright M, Muthukumar D, Badiger R (2018) A single centre experience of anti-PDL1 and anti-PD1 agents in treatment of NSCLC. Lung Cancer 115:36. https:\/\/doi.org\/10.1016\/S0169-5002(18)30113-2","journal-title":"Lung Cancer"},{"key":"2443_CR63","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ebiom.2017.07.014","volume":"22","author":"WB Yao","year":"2017","unstructured":"Yao WB, Ba Q, Li XG, Li HL, Zhang SD, Yuan Y, Wang F, Duan XH, Li JQ, Zhang WD, Wang H (2017) A natural CCR2 antagonist relieves tumor-associated macrophage-mediated immunosuppression to produce a therapeutic effect for liver cancer. EBioMedicine 22:58\u201367. https:\/\/doi.org\/10.1016\/j.ebiom.2017.07.014","journal-title":"EBioMedicine"},{"key":"2443_CR64","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.7150\/thno.54476","volume":"11","author":"SL Zhang","year":"2021","unstructured":"Zhang SL, Mao YQ, Zhang ZY, Li ZM, Kong CY, Chen HL, Cai PR, Han B, Ye T, Wang LS (2021) Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer. Theranostics 11:4155\u20134170. https:\/\/doi.org\/10.7150\/thno.54476","journal-title":"Theranostics"}],"container-title":["Journal of Mathematical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00285-026-02443-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00285-026-02443-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00285-026-02443-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:40:23Z","timestamp":1789652423000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00285-026-02443-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2443"],"URL":"https:\/\/doi.org\/10.1007\/s00285-026-02443-w","relation":{},"ISSN":["0303-6812","1432-1416"],"issn-type":[{"value":"0303-6812","type":"print"},{"value":"1432-1416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"24 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"32"}}